Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

This observational cohort study (n=30) explored perceptions of MDMA-Assisted Therapy among veterans with PTSD.

Conducted by Albany Research Institute, Inc., the study aimed to gather qualitative and quantitative data through interviews and questionnaires with veterans enrolled in VA care.

Participants, aged 18 and older, with an active diagnosis of PTSD, were included. They engaged in recorded interviews where they completed a brief story starter involving a fictitious character offered MDMA-Assisted Therapy. The interviews were transcribed, and recurring themes were identified through thematic analysis.

The primary outcomes measured included screening tools for depressive and PTSD symptoms, such as the Patient Health Questionnaire 9 and PTSD Checklist for DSM-5. The study, which started in August 2022 and concluded in March 2023, was conducted at Stratton VA Medical Center in Albany, New York.

Topic PTSD
Compound MDMA
Country United States of America
Visit trial
Status Completed
Results Published No
Start date 08 August 2022
End date 23 March 2023
Phase Not Applicable
Design Open
Type Observational
Generation First
Participants 30
Sex All
Age 18- 99
Therapy Yes

Trial Details

The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans diagnosed with PTSD and enrolled for care at the VA understand MDMA-assisted therapy for PTSD? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding MDMA-Assisted Therapy.

NCT Number NCT05895318

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.